HOSSEINI-MAZINANI S, JAFAR-NEJAD H, GHANDILI S. PATT ERN OF RESIS TANCE TO BETA-LACTAMS IN E.COLI ISOLATED FROM URINARY TRACT INFECTIONS IN IRAN. Med J Islam Repub Iran 2003; 16 (4) :209-212
URL:
http://mjiri.iums.ac.ir/article-1-734-en.html
From the National Research Center for Genetic Engineering and Biotechnology, Tehran, l.R. Iran. , hosseini@nrcgeb.ac.ir
Abstract: (6062 Views)
A total of 385 urine specimens from suspected urinary tract infections were
subjected to bacteriological analysis and susceptibility testing at a major university
hospital laboratory in Tehran.
A battery of eight beta-Iactam antibiotics, commonly prescribed in Iran, and
three third-generation cephalosporins (ceftazidime, ceftriaxone and ceftizoxime)
that are usually reserved for limited use in the hospital setting were tested against
E.coli urine isolates, using Kirby-Bauer disk diffusion method.
E. coli was the most common isolate from both the inpatient (37.8%) and
outpatient (30.5%) populations. The susceptibility testing revealed a high degree
of resistance to oxacillin, ampicillin, amoxycilIin, carbenicillin and cephradine.
Furthermore, a marked difference in the sensitivity/resistance ratio between the
inpatient and outpatient populations was observed.
The E.coli isolates exhibited the highest rate of resistance to oxacillin, ranging
from 49.4% in the outpatients to 81.6% in the inpatients. The frequency of the
isolate resistance to first-generation cephalosporins was less widespread. Despite
the absence of resistance to third-generation cephalosporins among the outpatient
isolates, a significant resistance to ceftazidime (9.6%) and ceftriaxone (8.8%)
was observed among the outpatient bacterial isolates. The susceptibility testing of
the E.coli isolates to a combination of amoxycillin and clavulanic acid revealed
6.9% resistance among outpatient and 12.5% among inpatient isolates.
These results are particularly significant in that this study was performed
immediately before the introduction of Co-amoxyclav to the Iranian drug market
and can be served as a basis for monitoring the spread of resistance to this drug in Iran.